Immunotherapy in Basal Cell Carcinoma

Basal cell carcinoma (BCC) is the most frequent of all cancers, with an increasing incidence. The first line therapy is surgical excision, but topical therapies can be used in low-risk superficial BCCs, while the more advanced, unresectable, or metastatic BCCs benefit from systemic therapies with he...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of clinical medicine 2024-09, Vol.13 (19), p.5730
Hauptverfasser:	Ungureanu, Loredana, Vasilovici, Alina Florentina, Halmágyi, Salomea-Ruth, Trufin, Ioana Irina, Apostu, Adina Patricia, Prisecaru, Manuela, Șenilă, Simona Corina
Format:	Artikel
Sprache:	eng
Schlagworte:	Apoptosis Basal cell carcinoma Cancer therapies Care and treatment Cell death Cytotoxicity Environmental risk Extracellular matrix Iatrogenesis Immunotherapy Lymphocytes Medical research Medicine, Experimental Physiological aspects Proteins Radiation therapy Review Risk factors Skin cancer Tumors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!